Seed+ · Biotech
Violet Therapeutics: Seed+
Develops first-in-class small molecule therapies for neurodegenerative disease via glial cell signaling platform
Funding history
Seed+ · This round$4.8M
Loading rounds…
Develops first-in-class small molecule therapies for neurodegenerative disease via glial cell signaling platform